Previous 10 | Next 10 |
The following healthcare companies have filed for mixed shelf offerings: More news on: Veru Inc., Cancer Genetics, Inc., Trevi Therapeutics, Inc., Healthcare stocks news, , Read more ...
Cancer Genetics (NASDAQ: CGIX ): Q1 GAAP EPS of -$0.56. More news on: Cancer Genetics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
RUTHERFORD, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced financial and operating results for the quarter ended March 31, 2020. ...
Cancer Genetics (NASDAQ: CGIX ): Q4 GAAP EPS of -$0.14. Revenue of $1.9M (+11.8% Y/Y) Shares +7% PM. Press Release More news on: Cancer Genetics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,
RUTHERFORD, N.J., June 01, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2019. OPERA...
Quick Take Lantern Pharma ( LTRN ) intends to raise $25 million in gross proceeds from an IPO of its common stock, per an amended registration statement . The company is advancing a pipeline of drug treatment candidates identified by its proprietary RADR platform. LTRN believes it can b...
Quick Take Lantern Pharma ( LTRN ) has filed to raise $28.75 million in an IPO of its common stock, according to an S-1 registration statement . The firm is developing a pipeline of drug candidates for the treatment of prostate, lung and other cancers. LTRN seeks to use its proprietary ...
Gainers: Sasol (NYSE: SSL ) +88% . More news on: Sasol Limited, Western Asset Mortgage Capital Corporation, Caleres, Inc., Stocks on the move, , Read more ...
Gainers: Camber Energy (NYSEMKT: CEI ) +61% . More news on: Camber Energy, Inc., Cancer Genetics, Inc., Micron Solutions, Inc., Stocks on the move, , Read more ...
RUTHERFORD, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or the “Company”), a leader in drug discovery and preclinical oncology and immuno-oncology services, today published a letter to shareholders from its Chie...
News, Short Squeeze, Breakout and More Instantly...
Cancer Genetics Inc. Company Name:
CGIX Stock Symbol:
NASDAQ Market:
Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines are designed to stimulate the body’s own immune system to destroy a tumor, by injecting fragments of cancer proteins found on the tumor. So far, none of the...
Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company” or “CGI”) (Nasdaq: CGIX), an emerg...
Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of preclinical and clinical pipelines with biopharma partners as well as the proprietary pipeline of the combined company RUTHERFORD, N.J., March 25, 2021 (GLOBE NEWSWIRE) ...